Home/Filings/4/0001209191-18-005852

4//SEC Filing

Collier David J 4

Accession 0001209191-18-005852

CIK 0001566044other

View on SEC.gov Company Profile

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 4:25 PM ET

Size

37.3 KB

Accession

0001209191-18-005852

Insider Transaction Report

Form 4

Period: 2018-01-29

Menlo Therapeutics, Inc.MNLO

Presidio Partners 2007 GP, L.P.

10% Owner

Transactions

Conversion
Series A Preferred Stock
2018-01-29−6,971→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (2,584 underlying)
Conversion
Common Stock
2018-01-29+2,584→ 1,418,005 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+127,269→ 2,395,068 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Series A Preferred Stock
2018-01-29−179→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (66 underlying)
Conversion
Common Stock
2018-01-29+66→ 36,358 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series C Preferred Stock
2018-01-29−343,310→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (127,269 underlying)
Conversion
Common Stock
2018-01-29+21,789→ 58,147 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Common Stock
2018-01-29+3,263→ 61,410 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series B Preferred Stock
2018-01-29−58,777→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (21,789 underlying)
Conversion
Common Stock
2018-01-29+849,794→ 2,267,799 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Series B Preferred Stock
2018-01-29−2,292,320→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (849,794 underlying)
Conversion
Series C Preferred Stock
2018-01-29−21,789→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (3,263 underlying)

CMEA VENTURES VII (PARALLEL) LP

10% Owner

Transactions

Conversion
Series A Preferred Stock
2018-01-29−179→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (66 underlying)
Conversion
Series C Preferred Stock
2018-01-29−343,310→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (127,269 underlying)
Conversion
Common Stock
2018-01-29+21,789→ 58,147 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series C Preferred Stock
2018-01-29−21,789→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (3,263 underlying)
Conversion
Common Stock
2018-01-29+2,584→ 1,418,005 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+849,794→ 2,267,799 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+127,269→ 2,395,068 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Series A Preferred Stock
2018-01-29−6,971→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (2,584 underlying)
Conversion
Series B Preferred Stock
2018-01-29−2,292,320→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (849,794 underlying)
Conversion
Series B Preferred Stock
2018-01-29−58,777→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (21,789 underlying)
Conversion
Common Stock
2018-01-29+66→ 36,358 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Common Stock
2018-01-29+3,263→ 61,410 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)

CMEA Ventures VII LP

10% Owner

Transactions

Conversion
Common Stock
2018-01-29+2,584→ 1,418,005 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+849,794→ 2,267,799 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Series B Preferred Stock
2018-01-29−58,777→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (21,789 underlying)
Conversion
Series C Preferred Stock
2018-01-29−21,789→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (3,263 underlying)
Conversion
Common Stock
2018-01-29+66→ 36,358 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Common Stock
2018-01-29+21,789→ 58,147 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series B Preferred Stock
2018-01-29−2,292,320→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (849,794 underlying)
Conversion
Series A Preferred Stock
2018-01-29−6,971→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (2,584 underlying)
Conversion
Common Stock
2018-01-29+127,269→ 2,395,068 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+3,263→ 61,410 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series A Preferred Stock
2018-01-29−179→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (66 underlying)
Conversion
Series C Preferred Stock
2018-01-29−343,310→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (127,269 underlying)

Collier David J

10% Owner

Transactions

Conversion
Common Stock
2018-01-29+849,794→ 2,267,799 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Series A Preferred Stock
2018-01-29−179→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (66 underlying)
Conversion
Series C Preferred Stock
2018-01-29−343,310→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (127,269 underlying)
Conversion
Common Stock
2018-01-29+66→ 36,358 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Common Stock
2018-01-29+3,263→ 61,410 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Common Stock
2018-01-29+2,584→ 1,418,005 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+21,789→ 58,147 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Common Stock
2018-01-29+127,269→ 2,395,068 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Series B Preferred Stock
2018-01-29−58,777→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (21,789 underlying)
Conversion
Series C Preferred Stock
2018-01-29−21,789→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (3,263 underlying)
Conversion
Series A Preferred Stock
2018-01-29−6,971→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (2,584 underlying)
Conversion
Series B Preferred Stock
2018-01-29−2,292,320→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (849,794 underlying)

Watson James F

10% Owner

Transactions

Conversion
Common Stock
2018-01-29+66→ 36,358 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series C Preferred Stock
2018-01-29−343,310→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (127,269 underlying)
Conversion
Series C Preferred Stock
2018-01-29−21,789→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (3,263 underlying)
Conversion
Common Stock
2018-01-29+21,789→ 58,147 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series A Preferred Stock
2018-01-29−179→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (66 underlying)
Conversion
Common Stock
2018-01-29+849,794→ 2,267,799 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Series B Preferred Stock
2018-01-29−2,292,320→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (849,794 underlying)
Conversion
Common Stock
2018-01-29+2,584→ 1,418,005 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+127,269→ 2,395,068 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+3,263→ 61,410 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series A Preferred Stock
2018-01-29−6,971→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (2,584 underlying)
Conversion
Series B Preferred Stock
2018-01-29−58,777→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (21,789 underlying)

Sohail Faysal A.

10% Owner

Transactions

Conversion
Common Stock
2018-01-29+66→ 36,358 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series B Preferred Stock
2018-01-29−2,292,320→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (849,794 underlying)
Conversion
Series A Preferred Stock
2018-01-29−179→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (66 underlying)
Conversion
Common Stock
2018-01-29+3,263→ 61,410 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series B Preferred Stock
2018-01-29−58,777→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (21,789 underlying)
Conversion
Common Stock
2018-01-29+849,794→ 2,267,799 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+127,269→ 2,395,068 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+2,584→ 1,418,005 total(indirect: By Presidio Partners 2007, L.P.)
Conversion
Common Stock
2018-01-29+21,789→ 58,147 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
Conversion
Series A Preferred Stock
2018-01-29−6,971→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (2,584 underlying)
Conversion
Series C Preferred Stock
2018-01-29−343,310→ 0 total(indirect: By Presidio Partners 2007, L.P.)
→ Common Stock (127,269 underlying)
Conversion
Series C Preferred Stock
2018-01-29−21,789→ 0 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)
→ Common Stock (3,263 underlying)

Footnotes (3)

[F1]Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock.
[F2]Securities directly held by Presidio Partners 2007, L.P. ("Presidio Partners"). Presidio Partners 2007 GP, L.P. ("Presidio GP") is the sole general partner of Presidio Partners. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio GP, and may be deemed to have voting control and investment power over the securities held by Presidio Partners, but disclaim beneficial ownership of the securities held by Presidio Partners, except to the extent of their pecuniary interest therein.
[F3]Securities directly held by Presidio Partners 2007 (Parallel), L.P. ("Presidio Parallel"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Menlo Therapeutics, Inc.

CIK 0001566044

→

Entity typeother

Related Parties

filerCIK 0001340886

Filing Metadata

Form type: 4
Filed: Jan 28, 7:00 PM ET
Accepted: Jan 29, 4:25 PM ET
Size: 37.3 KB

View on SEC.gov